Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Philip Jay Bierman"'
The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma
Autor:
Basem Magdy William, Navneeth Rao Bongu, Martin Bast, Robert Gregory Bociek, Philip Jay Bierman, Julie Marie Vose, James Olen Armitage
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 3, Pp 189-191 (2013)
Background: Serum lactate dehydrogenase is a non-specific marker for lymphoma whose prognostic significance is well established for both indolent and aggressive lymphomas at the time of diagnosis. The performance characteristics of this enzyme in pre
Externí odkaz:
https://doaj.org/article/18a3363505a9402591e1a6b3dbf9b1c2
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 6 (2012)
Clinical Medicine Insights: Oncology, Vol 6 (2012)
Primary central nervous system lymphoma (PCNSL) constitutes a rare group of extranodal non-Hodgkin's lymphoma (NHL) primarily of B cell origin. It occurs in both immuno-competent and immune-compromised patients. High dose methotrexate (HD-MTX) based
Autor:
David S. Snyder, Robert A. Krance, Pablo M. Parker, M R O'Donnell, Fahey Jl, A D Stock, Philip Jay Bierman, G M Schmidt, Anthony S. Stein, A P Nademanee
Publikováno v:
Journal of Clinical Oncology. 5:1822-1826
Twenty patients (age range, 4 to 48 years; median age, 36 years) with de novo or drug-induced myelodysplastic syndromes or myeloproliferative disorders were treated with myeloablative immunosuppressive therapy followed by bone marrow transplantation
Autor:
David S. Snyder, Philip Jay Bierman, A P Nademanee, Stephen J. Forman, M R O'Donnell, James A. Lipsett, G M Schmidt, KG Blume
Publikováno v:
Blut. 55:11-18
Allogeneic bone marrow transplantation from histocompatible sibling donors was performed in six patients with extranodal involvement of high grade lymphoma during first complete remission. Five patients had lymphoblastic lymphoma and one had diffuse
Autor:
David S. Snyder, M R O'Donnell, G M Schmidt, Fahey Jl, Philip Jay Bierman, A P Nademanee, S.J. Forman, Anthony S. Stein, Pablo M. Parker, KG Blume
Publikováno v:
Blood. 70:587-588
We report the treatment outcome of allogeneic bone marrow transplantation in ten patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Six patients are alive and well for 6 to 30 months (median 19 months) after transplantation.